|
HSPA9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.37429999789308E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92350999999036E-05 |
| Normal-vs-Stage2 |
8.993600E-02 |
| Normal-vs-Stage3 |
6.89779999785145E-08 |
| Normal-vs-Stage4 |
1.357680E-03 |
| Stage1-vs-Stage2 |
4.815400E-01 |
| Stage1-vs-Stage3 |
5.763800E-02 |
| Stage1-vs-Stage4 |
6.575800E-01 |
| Stage2-vs-Stage3 |
9.025600E-02 |
| Stage2-vs-Stage4 |
4.121600E-01 |
| Stage3-vs-Stage4 |
3.144600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12320000025912E-07 |
| Normal-vs-AfricanAmerican |
4.996000E-04 |
| Normal-vs-Asian |
1.277870E-03 |
| Caucasian-vs-AfricanAmerican |
4.237600E-01 |
| Caucasian-vs-Asian |
3.987800E-01 |
| AfricanAmerican-vs-Asian |
6.157000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62309999884869E-08 |
| Normal-vs-Female |
8.162500E-04 |
| Male-vs-Female |
3.641600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.38470004748837E-09 |
| Normal-vs-Age(41-60Yrs) |
1.01539999997069E-06 |
| Normal-vs-Age(61-80Yrs) |
2.0846999999935E-05 |
| Normal-vs-Age(81-100Yrs) |
4.908600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.018430E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.544100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.167700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.162000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.220800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.237200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.823040E-01 |
| Normal-vs-Grade 2 |
3.5468000000316E-06 |
| Normal-vs-Grade 3 |
2.31159999999342E-05 |
| Normal-vs-Grade 4 |
1.71970999999216E-05 |
| Grade 1-vs-Grade 2 |
9.703600E-01 |
| Grade 1-vs-Grade 3 |
9.348400E-01 |
| Grade 1-vs-Grade 4 |
5.443600E-01 |
| Grade 2-vs-Grade 3 |
8.778400E-01 |
| Grade 2-vs-Grade 4 |
1.891970E-01 |
| Grade 3-vs-Grade 4 |
2.972200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.988200E-02 |
| Normal-vs-ccB subtype |
2.95460000909742E-09 |
| ccA subtype-vs-ccB subtype |
1.53363999999545E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.91029999993842E-07 |
| Normal-vs-N1 |
1.888760E-01 |
| N0-vs-N1 |
8.107400E-01 |
|
|
